Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.50, moving -6.17% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.41%. At ...

Rosalind, a biology-focused AI model released as a research preview for select U.S. enterprise users, underscoring rising ...

If you’ve been on X or Reddit in recent weeks, you’ve likely seen images created by an upcoming model from OpenAI floating ...

Recursive Superintelligence raises $500M to accelerate AI innovation, signaling strong investor confidence in next-gen ...

The reason this matters so much right now is that AI and humans are fundamentally different kinds of intelligence. Despite ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to ...

OpenAI has introduced an early version of an AI model designed to expedite drug discovery, competing directly with tech giant ...

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

The model will be available initially as a research preview to some of the company’s business customers, OpenAI said ...